Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-09 Sale |
2020-11-12 6:30 pm |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner |
39,391 | $91.79 | $3,615,680 | 4,807,997 (Indirect Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 8:53 pm |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman |
40,000 | $90.59 | $3,623,600 | 4,887,388 (Indirect Direct) |
View |
| 2020-09-23 Sale |
2020-09-25 7:00 pm |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner |
25,535 | $99.73 | $2,546,625 | 4,788,606 (Indirect Direct) |
View |
| 2020-09-16 Sale |
2020-09-18 6:25 pm |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner |
40,000 | $101.58 | $4,063,200 | 4,814,141 (Indirect Direct) |
View |
| 2020-09-09 Sale |
2020-09-11 9:21 pm |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner |
40,000 | $102.73 | $4,109,200 | 4,854,141 (Indirect Direct) |
View |
| 2020-04-29 Sale |
2020-05-01 8:13 pm |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner |
40,000 | $74.13 | $2,965,000 | 7,097,928 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-12-03 Other |
2021-12-07 9:10 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Director |
3,500,008 | $0 | 4,843,413 (Indirect) |
View |
| 2021-12-03 Other |
2021-12-07 9:09 pm |
N/A N/A |
Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director |
124,999 | $0 | 212,696 (Indirect) |
View |
| 2021-06-01 Option Award |
2021-06-02 7:33 pm |
N/A 2031-06-01 |
Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director |
3,571 | $0 | 3,571 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 7:22 pm |
N/A 2031-02-23 |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman |
41,714 | $0 | 41,714 (Direct) |
View |
| 2020-07-02 Option Award |
2021-02-17 9:00 pm |
N/A 2030-07-02 |
Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director |
3,571 | $0 | 3,571 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 6:30 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner |
39,391 | $26.45 | 4,807,997 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 6:30 pm |
N/A 2022-03-09 |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman 10% Owner |
39,391 | $0 | 4,807,997 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 8:53 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman |
40,000 | $26.45 | 4,887,388 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 8:53 pm |
N/A 2022-03-09 |
Emergent BioSolutions Inc. | EBS | El-Hibri Fuad Chairman |
40,000 | $0 | 4,887,388 (Direct) |
View |
| 2020-07-27 Option Award |
2020-07-29 9:18 pm |
N/A 2030-07-26 |
Aptevo Therapeutics Inc. | APVO | El-Hibri Fuad Director |
1,492 | $0 | 1,492 (Direct) |
View |